The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial reporting of NRG-LU001 (NCT02186847), randomized phase II trial of concurrent chemoradiotherapy (CRT) +/- metformin in locally advanced Non-Small Cell Lung Cancer (NSCLC).
 
Theodoros Tsakiridis
No Relationships to Disclose
 
Chen Hu
No Relationships to Disclose
 
Heath Devin Skinner
No Relationships to Disclose
 
Rafael Santana-Davila
No Relationships to Disclose
 
Bo Lu
No Relationships to Disclose
 
Jeremy J. Erasmus
No Relationships to Disclose
 
Anthony Doemer
No Relationships to Disclose
 
Gregory M.M. Videtic
Speakers' Bureau - AstraZeneca
 
James Coster
No Relationships to Disclose
 
Xuezhong Yang
No Relationships to Disclose
 
Richard Lee
No Relationships to Disclose
 
Maria Werner-Wasik
Stock and Other Ownership Interests - Illumina (I)
Research Funding - Elekta
Patents, Royalties, Other Intellectual Property - signal transduction inhibitor in lymphoma (I)
 
Philip E. Schaner
No Relationships to Disclose
 
Steven Eric McCormack
No Relationships to Disclose
 
Benjamin Esparaz
No Relationships to Disclose
 
Ronald McGarry
No Relationships to Disclose
 
Jose G. Bazan
No Relationships to Disclose
 
Timothy Struve
No Relationships to Disclose
 
Jeffrey D. Bradley
Honoraria - AstraZeneca/MedImmune
Consulting or Advisory Role - AstraZeneca/MedImmune
Travel, Accommodations, Expenses - Mevion Medical Systems